Lifecore Biomedical, Inc. (LFCR)
6.38
-0.02
(-0.31%)
USD |
NASDAQ |
Nov 06, 10:15
Lifecore Biomedical Gross Profit Margin (Quarterly) : 26.96% for Sept. 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 26.96% |
| June 30, 2026 | 35.34% |
| March 31, 2026 | 19.24% |
| December 31, 2025 | |
| September 30, 2025 | |
| May 31, 2025 | 38.37% |
| February 28, 2025 | 28.01% |
| November 30, 2024 | 34.04% |
| August 31, 2024 | 21.81% |
| May 31, 2024 | 45.59% |
| February 29, 2024 | 33.31% |
| November 30, 2023 | 33.02% |
| August 31, 2023 | 11.12% |
| May 31, 2023 | 26.60% |
| February 28, 2023 | 32.21% |
| November 30, 2022 | 25.97% |
| August 31, 2022 | 25.20% |
| May 31, 2022 | 45.15% |
| February 28, 2022 | 34.40% |
| November 30, 2021 | 33.86% |
| August 31, 2021 | 25.06% |
| May 31, 2021 | 32.46% |
| February 28, 2021 | 32.31% |
| November 30, 2020 | 15.76% |
| August 31, 2020 | 12.05% |
| Date | Value |
|---|---|
| May 31, 2020 | 15.43% |
| February 29, 2020 | 13.11% |
| November 30, 2019 | 10.88% |
| August 31, 2019 | 11.06% |
| May 31, 2019 | 17.16% |
| February 28, 2019 | 13.87% |
| November 30, 2018 | 13.56% |
| August 31, 2018 | 13.10% |
| May 31, 2018 | 17.59% |
| February 28, 2018 | 13.67% |
| November 30, 2017 | 12.18% |
| August 31, 2017 | 16.24% |
| May 31, 2017 | 15.43% |
| February 28, 2017 | 17.16% |
| November 30, 2016 | 13.95% |
| August 31, 2016 | 15.97% |
| May 31, 2016 | 16.84% |
| February 29, 2016 | 9.95% |
| November 30, 2015 | 12.29% |
| August 31, 2015 | 13.28% |
| May 31, 2015 | 13.89% |
| February 28, 2015 | 12.19% |
| November 30, 2014 | 11.81% |
| August 31, 2014 | 10.62% |
| May 31, 2014 | 13.35% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 55.48% |
| Bio-Rad Laboratories, Inc. | 53.12% |
| Bruker Corp. | 47.78% |
| Azenta, Inc. | 44.89% |
| Danaher Corp. | 59.34% |
Gross Profit Margin (Quarterly) Related Metrics
| Profit Margin (Quarterly) | -158.3% |
| Operating Margin (Quarterly) | -3.53% |